The most important financial indicators for the company Spil Med S.r.l. - Unique Identification Number 21255333:
sales in 2023 was
14.729
euro, registering a net profit of
-27.069
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -86.9%, from 112.425 euro in the year 2022, to 14.729 euro in 2023.
The Net Profit decreased by -25.797 euro, from 25.876 euro in 2022, to 0 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Spil Med S.r.l. - CUI 21255333
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
98.675
163.013
175.160
166.007
177.519
158.585
142.537
133.050
150.293
138.539
Current Assets
63.287
86.599
82.655
143.548
192.790
221.844
208.136
211.287
206.621
106.754
Inventories
1.462
2.852
3.399
4.256
8.052
10.289
4.406
4.548
5.964
0
Receivables
45.229
55.116
47.624
50.577
81.262
38.149
21.507
35.600
32.602
401
Cash
16.596
28.631
31.632
88.715
103.475
173.405
182.223
171.139
168.055
106.353
Shareholders Funds
49.620
77.539
91.278
114.487
140.364
145.038
156.135
186.245
212.699
183.767
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
112.342
172.072
166.537
195.068
229.944
235.390
194.537
158.093
144.216
61.526
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
4941
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
106.754 euro in 2023 which includes Inventories of
0 euro, Receivables of
401 euro and cash availability of
106.353 euro.
The company's Equity was valued at
183.767 euro, while total Liabilities amounted to
61.526 euro.
Equity decreased by -28.287 euro, from 212.699 euro in 2022, to 183.767 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Spil Med S.r.l.